CBD (cannabidiol) and CBG (cannabigerol) are non-psychoactive cannabinoids from the hemp plant that interact with the equine endocannabinoid system (ECS) to promote balance and homeostasis. CBD may reduce inflammation and anxiety, while CBG shows promise for bone health and pain relief, making them valuable for equine wellness. Research indicates CBD is safe at doses up to 2 mg/kg orally in horses, with detectable effects within 24 hours (Gleeson et al., Veterinary Immunology and Immunopathology, 2023).

Yes, when sourced from hemp with less than 0.3% THC, CBD and CBG are generally safe for horses. Studies show no serious adverse effects at doses of 0.5–3 mg/kg over 6 weeks, though mild side effects like soft manure or drowsiness may occur. Always consult a veterinarian, especially for horses with liver or kidney conditions, as long-term high-dose effects are less studied (Williams et al., Frontiers in Veterinary Science, 2024).

CBD may support anxiety, pain, and arthritis by reducing inflammatory markers, as seen in studies with horses showing improved quality of life at 0.03 mg/kg over 14 days. CBG’s potential for bone health is emerging, with research suggesting anti-inflammatory benefits that could aid joint conditions. More studies are needed to confirm efficacy for lameness or ulcers (Smith et al., Journal of Equine Veterinary Science, 2023).

Terpenes are aromatic compounds in hemp that enhance CBD and CBG effects through the “entourage effect.” Linalool may promote calm, myrcene supports relaxation, and limonene may reduce stress. Research on terpene-cannabinoid combinations in horses is limited, but data from other species suggests they improve overall balance when included in full-spectrum formulations (Russo, British Journal of Pharmacology, 2011).

Start with a low dose, such as 0.5 mg/kg of body weight daily (e.g., 250 mg for a 500 kg horse), split morning and night. Adjust based on response, up to 2 mg/kg, as studies show safety at this level. It may take 1–2 weeks to notice effects. Consult a vet and use products with clear dosing guidelines (Gleeson et al., Veterinary Immunology and Immunopathology, 2023).

Yes, CBD can affect liver metabolism, potentially altering how other drugs (e.g., NSAIDs) are processed. Research indicates this risk is low at typical doses (1–3 mg/kg), but avoid combining with medications without veterinary guidance, especially for competition horses due to detection concerns (Williams et al., Frontiers in Veterinary Science, 2024).

There’s no specific age limit, and senior horses tolerate 2 mg/kg doses well, per studies. However, horses with pre-existing liver, kidney, or systemic conditions should be monitored, as research on compromised health is sparse. Pregnant or nursing mares require vet approval due to limited data (Smith et al., Journal of Equine Veterinary Science, 2023).

CBD is detectable in plasma for up to 24 hours at 2 mg/kg, with metabolites like 7-COOH-CBD persisting up to 264 hours. Detection times vary by dose and formulation, posing risks for competition horses under FEI rules. Urine detection may last 8–12 days, depending on THC traces (Williams et al., Frontiers in Veterinary Science, 2024).

No, CBD and CBG are banned by the FEI and may result in doping violations. Studies show detectable levels in blood and urine post-administration (e.g., 1 mg/kg oral dose), with elimination varying by individual. Avoid use in competitive contexts unless clearance is confirmed (FEI Guidelines, 2023).

Select products with third-party lab testing (COA) confirming CBD, CBG, and terpene content, free of contaminants like heavy metals or pesticides. Opt for full-spectrum or broad-spectrum formulations for the entourage effect, as supported by research on enhanced efficacy in other species (Russo, British Journal of Pharmacology, 2011).

The endocannabinoid system (ECS) is a network of receptors (CB1, CB2) and enzymes in horses that regulates pain, mood, and inflammation. CBD and CBG bind to these receptors, influencing ECS activity to promote balance. Research shows the equine ECS responds to cannabinoids, with studies indicating reduced stress markers in horses at 0.5 mg/kg CBD doses over 7 days, suggesting benefits for anxiety and recovery (Gleeson et al., Veterinary Immunology and Immunopathology, 2023). This system’s role is still being explored, but it underpins Quietude’s natural approach to equine health.

Full-spectrum CBD contains all hemp plant compounds—CBD, CBG, terpenes, and trace cannabinoids—working together via the “entourage effect” to enhance therapeutic benefits. Studies suggest full-spectrum formulations may be more effective than isolates for reducing inflammation and anxiety in animals, with equine research showing improved outcomes at 1 mg/kg compared to isolated CBD (Russo, British Journal of Pharmacology, 2011; Smith et al., Journal of Equine Veterinary Science, 2023). This synergy supports better absorption and efficacy, making it ideal for Quietude’s high-potency products like the 16,000mg CBD Tincture.